GlobalData, the industry analysis specialist, has released its new report, “Crohn’s Disease (CD) Therapeutics – Pipeline Assessment and Market Forecasts to 2018”. The report is an essential source of information and analysis on the global Crohn’s Disease Therapeutics market. The report identifies the key trends shaping and driving the global Crohn’s Disease Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Crohn’s Disease Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
GlobalData estimated the global Crohn’s disease (CD) therapeutics market to be worth at $3.6 billion in 2010. From 2005-2010, the market grew at a compound annual growth rate (CAGR) of 25.2%, from $1.2 billion in 2005 to $3.6 billion in 2010. The high growth rate during 2005-2010 is primarily attributed to the launches of the biologics such as Humira (adalimumab), Cimzia (certolizumab pegol) and Tysabri (natalizumab) and increased uptake of Remicade (infliximab) and Entocort EC (budesonide). The CD therapeutics market is forecast to show moderate growth at a CAGR of 2.6% for the next eight years, to reach $4.4 billion by 2018. This will come as a result of the patent expiries of Remicade and Entocort EC and the subsequent launch of biosimilars. The CD therapeutics pipeline is strong, with first-in-class molecules in the late stage of development, which when launched are expected to off-set generic incursion and drive the market.
Note: This is a on-demand report and will be delivered within 3 business days of the purchase (excluding weekends).
Scope :
The report provides information on the key drivers and challenges for the CD therapeutics market. Its scope includes -
- Annualized information for the CD therapeutics market in seven key markets (the US, France, Germany, Italy, Spain, the UK and Japan) with revenue data from 2005–2010 and forecasts to 2018.
- Pipeline analysis data which provides information on different phases, mechanisms of action being developed and emerging trends. Pipeline candidates fall under major therapeutic classes such as interleukin inhibitors and enzyme inhibitors, stem cell therapy, integrin antagonists, tumor necrosis inhibitors and immunomodulators.
- Analysis of current and future competition in the global CD therapeutics market. Key market companies covered are: GlaxoSmithKline plc, Johnson & Johnson, Ocera Therapeutics, Inc., Osiris Therapeutics, Inc., Takeda Pharmaceutical Company Limited, and Otsuka Pharmaceutical Co., Ltd.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for the CD therapeutics market.
- Analysis of key recent licensing and partnership agreements in the CD therapeutics market.
- Annualized information for the CD therapeutics market in seven key markets (the US, France, Germany, Italy, Spain, the UK and Japan) with revenue data from 2005–2010 and forecasts to 2018.
- Pipeline analysis data which provides information on different phases, mechanisms of action being developed and emerging trends. Pipeline candidates fall under major therapeutic classes such as interleukin inhibitors and enzyme inhibitors, stem cell therapy, integrin antagonists, tumor necrosis inhibitors and immunomodulators.
- Analysis of current and future competition in the global CD therapeutics market. Key market companies covered are: GlaxoSmithKline plc, Johnson & Johnson, Ocera Therapeutics, Inc., Osiris Therapeutics, Inc., Takeda Pharmaceutical Company Limited, and Otsuka Pharmaceutical Co., Ltd.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for the CD therapeutics market.
- Analysis of key recent licensing and partnership agreements in the CD therapeutics market.
Reasons to buy
The report will enhance your decision making capability. It will allow you to -
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and through identification of companies with the strongest pipelines.
- Develop business strategies through understanding of the trends which shape and drive the global CD therapeutics market.
- Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global CD therapeutics market in the future.
- Formulate effective sales and marketing strategies through understanding of the competitive landscape and analysis of the performance of various competitors.
- Identify emerging companies with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying market categories and segments that present the best opportunities for consolidations, investments and strategic partnerships.
- What’s the next big thing in the global CD therapeutics market landscape? Identify, understand and capitalize.
- Develop business strategies through understanding of the trends which shape and drive the global CD therapeutics market.
- Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global CD therapeutics market in the future.
- Formulate effective sales and marketing strategies through understanding of the competitive landscape and analysis of the performance of various competitors.
- Identify emerging companies with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying market categories and segments that present the best opportunities for consolidations, investments and strategic partnerships.
- What’s the next big thing in the global CD therapeutics market landscape? Identify, understand and capitalize.
Latest Market Research Reports:
- Blood Glucose Monitoring Devices (Meters, Test Strips, Lancets) – Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
- Latino Foodservice Trends in the U.S.
- Annual Forecasting Food & Grocery 2015
- Global Small and Medium Scale LNG Industry Outlook to 2015
About Us:
ReportsnReports.com is an online market research library of 135,000+ reports and in-depth studies of over 5000 micro markets. Our database includes reports by leading publishers from across the globe. We provide 24/7 online and offline support service to our customers. Visit http://www.reportsnreports.com/ for more details.
Contact:
Priyank Tiwari
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-391-5441
sales@reportsandreports.com
Visit our Market Research Blog @ http://www.reportsnreportsblog.com/
Connect with us on:
Twitter @ http://www.twitter.com/marketsreports
No comments:
Post a Comment